Recruiting at 6 sites No phase Osteoarthritis, Knee

Osteoarthritis, Knee study: MISHA Knee System vs Non-Surgical Treatment

Official title MOTION Clinical Trial

ClinicalTrials.gov ID: NCT06843980

What this study is testing

What it's testing
This study is testing whether the MISHA Knee System works better than non‑surgical treatment for knee osteoarthritis.
Who it's for
You may be able to join if you have medial knee osteoarthritis.
What's involved
You will be assigned by chance, like a coin toss, to receive the MISHA Knee System (a small knee implant) or non‑surgical care. You will attend study visits and have check‑ups to see how you feel.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Adults

You may be able to join if

  • Activity exacerbated knee pain isolated to the medial compartment and not global in nature
  • WOMAC pain ≥ 40
  • Failed to find relief in non-surgical treatment modalities Key

You likely can't join if

  • Large medial osteophyte(s) or considerable extruded meniscus that may interfere with the placement or function of the device
  • Poor bone quality (e.g., bony erosion, osteopenia, osteoporosis)
  • Ligamentous instability
  • Active or recent knee infection
  • Inflammatory joint disease, including sequelae of viral infections
  • Suspected or documented allergy or hypersensitivity to cobalt, chromium, nickel or other metals
See the full eligibility criteria
Who can join
  • Activity exacerbated knee pain isolated to the medial compartment and not global in nature
  • WOMAC pain ≥ 40
  • Failed to find relief in non-surgical treatment modalities Key
What rules you out
  • Large medial osteophyte(s) or considerable extruded meniscus that may interfere with the placement or function of the device
  • Poor bone quality (e.g., bony erosion, osteopenia, osteoporosis)
  • Ligamentous instability
  • Active or recent knee infection
  • Inflammatory joint disease, including sequelae of viral infections
  • Suspected or documented allergy or hypersensitivity to cobalt, chromium, nickel or other metals
  • History of keloid, hypertrophic or contracture scaring
  • Propensity for restrictive scar formation or adhesions with prior procedures

The study team makes the final eligibility decision.

Where it is enrolling

  • Oceanside, California, United States
  • Chicago, Illinois, United States
  • Oak Brook, Illinois, United States
  • Omaha, Nebraska, United States
  • Columbus, Ohio, United States
  • San Antonio, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Oceanside, California, United States; Chicago, Illinois, United States; Oak Brook, Illinois, United States; Omaha, Nebraska, United States; Columbus, Ohio, United States; San Antonio, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.